Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Kidney Neoplasms × Ipilimumab × Clear all

Phase

Phase 2 6 Phase 3 4 Phase 1 4 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Melanoma 2 Skin Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Nivolumab 4 cabozantinib 2 Sodium Chloride 2 Saline Solution 2 Everolimus 2 Anesthesia, Epidural 2 polyethylene glycol 3350 1 aldesleukin 1 Tobacco Use Cessation Devices 1 Standard of Care 1 Solutions 1 Sevoflurane 1 Radiotherapy 1 Psychiatric Rehabilitation 1 Propofol 1 Polymerase Chain Reaction 1 Papaverine 1 Nutrition Therapy 1 Neuroleptanalgesia 1 Lidocaine 1 Ipilimumab 1 Intubation 1 Hydroxyethyl Starch Derivatives 1 HES 130-0.4 1 Glucose 1 Gene Expression Profiling 1 Fentanyl 1 Early Intervention, Educational 1 Dexmedetomidine 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04513522 2025-07-11

CheckMate 7C9

Bristol-Myers Squibb

Phase 4 Completed

101 enrolled 12 charts

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡